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ABSTRACT: The present study was designed in order to evaluate the effi cacy and safety of Cycostat® 66G in the 
prevention and control of coccidiosis in breeding does after experimentally induced infection with common Eimeria spp. 
at the age of 18 wk. The inoculum was prepared based on faecal samples collected on farms in the Czech Republic. 
A total of 94 young and pregnant does were divided into 4 groups and enrolled in the study. The zootechnical, clinical 
and parasitological results of 2 control groups were compared, a non-infected non-treated (NI-NT) and an infected 
non-treated (I-NT), and 2 infected and dietary supplemented groups, with 50 (I-50) and 66 mg/kg (I-66) robenidine, 
respectively. Does in the I-NT group showed a signifi cant drop in weight gain and feed intake during the fi rst 14 d after 
inoculation. No treatment related effects on the weight development of the does were observed, although does in the 
I-NT group always had approximately ± 200 g lower body weight. Litter size (live born) was not signifi cantly different at 
either the fi rst or second parturition and amounted to 9.0, 8.2, 10.1 and 9.8 (1st litter) and 11.3, 10.4, 10.1 and 11.0 (2nd 
litter) in NI-NT, I-NT, I-50 and I-66 does, respectively. At weaning, both in the 1st and 2nd cycle, the highest litter weight 
was obtained in the I-50 and I-66 groups. Litter weaning weight values for I-66 (litter 2) were higher but not signifi cant 
(P=0.069) compared to the NI-NT litters. The lowest young mortality was also observed in the I-66 litters, both in the 
fi rst and second cycles. Between 6 to 11 d after inoculation, the oocyst excretion of both supplemented groups was 
reduced by more than 90% in comparison to the I-NT. Supplementation with Cycostat® 66G diminished the excretion of 
E. fl avescens and E. intestinalis, the most pathogenic species, by 100%. The excretion of E. magna was reduced by >90 
and 100% for the I-50 and I-66 groups, respectively. The reduction in oocyst excretion of E. media was less pronounced. 
It was concluded that Cycostat® 66G supplemented in the feed at a concentration of 50 or 66mg/kg was able to prevent 
coccidiosis in breeding does after experimental inoculation.
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INTRODUCTION
Coccidiosis still represents the main parasitological infection in rabbit units (Coudert et al., 2003; Licois 
and Marlier, 2008). Rabbits can be infected by a large number of species; however, only 11 species have 
been isolated in pure culture and characterised (Licois and Marlier, 2008). All are of the genus Eimeria of 
which eight are of economic importance (Bhat et al., 1996). The most dominant Eimeria species isolated 
today in professional rabbit husbandry are intestinal species: E. magna and E. media (Coudert et al., 
2003). Even low levels of infection usually cause intestinal malabsorption, increased feed conversion and 
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delayed growth (Coudert, 1997). The importance of the disease increased even more with the onset of 
Epizootic Rabbit Enteropathy (Coudert et al., 2000). 
The most applied method of control and prevention of coccidiosis in intensive rabbit production, 
except for farm management (all-in, all-out), hygiene and disinfection, is the prophylactic inclusion of 
anticoccidials in the feed. Cycostat® 66G is a coccidiostat containing 6.6% robenidine hydrochloride and 
is well known for its efficacy against coccidiosis in rabbits (Peeters and Halen, 1980). A regular update 
of the efficacy and safety provides useful information on the performance of the product under current 
housing conditions (Vancraeynest et al., 2008) and is legally required in view of the authorization process.
The study objective was to evaluate the efficacy of two different dietary supplementation regimes of 
Cycostat® 66G for the prevention of coccidiosis in conventional breeding rabbits under practical housing 
conditions and husbandry available today. For this purpose, commercially obtained young rabbit breeders 
were orally infected with recent isolates of rabbit specific Eimeria. 
MATERIAL AND METHODS
Animals and procedures
One hundred and twenty young does were purchased at a commercial farm at the age of 10-11 wk. They 
belonged to the progeny of the Institutes’ dam line and were later on inseminated with males of the 
Institutes’ sire line (Maertens, 1992). Animals were vaccinated at arrival against Rabbit Hemorrhagic 
Disease (RHD) (Hebovak 88T, Eurovet Animal Health). These young does were dietary treated with 
salinomycine (20 mg/kg) for 2 wk to obtain coccidia-free animals for the study. 
The females were uniquely identified with ear tags and randomised into 4 experimental groups one week 
before the start of the trial (Table 1). At study start (0 d) the does were 16-17 wk old and inseminated for 
the first time with mixed semen. 
Only the pregnant does were retained after the control of gestation on 13 d of the trial. Because the overall 
gestation success was rather low (62%) and lower than expected, the intended 20 pregnant females/group 
were not reached. Therefore, it was decided to inseminate the non-pregnant females a second time on 
study 20 d; this is 20 d after the first unsuccessful insemination. These females were handled in exactly 
the same way according to the experimental design and schedule with the only difference being the time 
delay of 20 d. In total, 94 young pregnant females were observed during the study.
At parturition, after counting the original litter size, litters were equalised intra-group at 7-9 kits/litter 
or 9-10 kits/litter depending of the number of kits born alive, for litter 1 and 2, respectively. Since the 
females were inseminated on the same day, 31 d was considered as the day of parturition and all litters 








A =NI-NT − − NA1 NA1
B =I-NT + − NA1 NA1
C =I-50 + + Robenidine 50 mg/kg
D =I-66 + + Robenidine 66 mg/kg
NI-NT: a non-infected non-treated, I-NT: and an infected non-treated, I-50: infected and dietary supplemented with 50 mg/kg 
robenidine, I-66: infected and dietary supplemented with 66 mg/kg robenidine.
1NA = Not Applicable, 
Table 1: Experimental design.
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The experimental protocol was approved by the Use and Care Committee of the ILVO Research Institute 
in September 2007. 
Housing
The trial took place in one of the experimental rabbit houses of the ILVO Animal Science Unit and started 
on 21 September 2007. The rabbit house compartments had a net floor space of 95 m² (9.5 ×10 m) and 
contained 96 flat-deck cages measuring 0.70 ×0.46 and 0.50 m height. Before the experiment, all cages 
were cleaned intensively and heat-treated (gas burner). The wire cages were of zinc-coated wire with a 3 
mm diameter and rectangular slats of 75×15 mm. Twice a week, the droppings were removed.
Females were housed individually and each cage was equipped with a feeder and a nipple drinker. The 
cages were aligned in 6 rows (16 cages): 2 against the walls and 2 double rows in the middle of the 
compartment. Each cage was also equipped with an outside nestbox (30×28 cm). Four days before 
parturition, females were allowed to enter their outside placed nest box filled with wood shavings.
Infected treatment groups were housed together in the same compartment. The infected untreated animals 
(I-NT) were housed on 2 rows separated from the 2 infected and treated groups (I-50 and I-66). The non-
infected untreated (NI-NT) does were housed in a separate compartment, equipped with identical cages, 
to avoid contamination from the infected rabbits.
The trial site was equipped with dynamic (over-underpressure) ventilation with 2 air inlets at the door 
side of each compartment and air extraction at the other side of the room. The ventilation rate varied 
between 1 and 2 (winter conditions) m3/kg BW/h, depending on the outside temperature and occupation 
of the house. The incoming air was heated before the inlet of the experimental rooms and distributed over 
the different compartments. With this acclimatisation system, a temperature of 17±2°C was maintained 
throughout the experiment.
The rabbit house was windowless. Illumination was provided by electric bulbs, placed regularly in the 
centre of each row. Females received a lighting schedule of 16h of light per day throughout the entire 
experimental period. Illumination was automatically regulated by means of a 24 h-clock.
Day of study Activity
0 Insemination 1. Collection of faecal samples
13 Inoculation
19-24 Collection of faecal samples
31 Parturition 1
38-39 Collection of faecal samples
46 Insemination 2
55-57 Collection of faecal samples
62 Weaning litter 1
77 Parturition 2
84-86 Collection of faecal samples
101-103 Collection of faecal samples
108 Weaning litter 2
Table 2: Scheme of main activities.
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Feeding
Breeding does always received their respective experimental diet ad libitum from the first insemination 
onwards. Each female had a bucket on top of the cage allowing individual feed control as scheduled 
between insemination 1, inoculation, 28 d and when the kits were 1 and 3 wk old. 
All the diets were prepared and pelleted (3 mm diameter and 0.8 cm long) at the ILVO-Animal Science 
feed mill. The diet was formulated to have an energy content of 10.5 MJ/kg and a crude protein content 
of 18.0%. The feed composition and the main nutrients calculated are presented in Table 3. No growth 
promoter was added to the experimental diets. The test substance (Cycostat® 66G) was mixed into the 
meal before the pelleting process.
Supplemented groups were given either 50 mg/kg or 66 mg/kg robenidine hydrochloride in their feed. 
These doses correspond to the lowest and highest recorded supplementation regimen for Cycostat® 66G in 
rabbits. The control groups received blank feed from the same batch. Kits received the same feed as their 
mothers, as they used the same feeder till weaning age. 
A sample of each of the experimental diets was taken to determine the robenidine hydrochloride content. 
In total, 2 feed batches were prepared of each experimental diet.
Drinking water was supplied by an internal water system network stemming from a water well. Each cage 
was connected with this system by one nipple drinker.
Inoculation
The inoculum was provided by Dr Dominique Licois from the INRA Tours (France). The inoculum was 
based on faecal samples collected by Michal Pakandl (Biology Centre AS CR, Institute of Parasitology, 
Branišovská 31, 37005 České Budějovice, Czech Republic) on farms in the Czech Republic in June 
2007. The oocysts from these faecal samples were extracted and the Eimeria spp. were propagated in 
coccidia free rabbits. The derived inoculum was equilibrated with historical strains of Eimera spp. isolated 
from rabbit farms in France in order to obtain an acceptable pathogenic inoculum with the following 
composition: E. magna: 29%; E. media: 26%; E. perforans: 8%; E. intestinalis: 19% and E. flavescens: 
18%.
Ingredients Calculated nutrients (g kg–1 )1
Alfalfa meal 15 26.0 Crude protein 180
Wheat shorts 22.1 Ash 105
Sunflower meal 27 14.0 Ether extract 46
Wheat 11.0 Crude fibre 155
Beet pulp 8.0 NDF 290
Soybean meal 44 3.0 ADF 180
Full-fat soybeans 6.0 ADL 43
Flax chaff 3.0 DE (MJ/kg ) 10.5
Fat 1.0
Molasses 3.0
Minerals and vitamins 2.8
Amino acids 0.10
Table 3: Ingredient composition and calculated nutrient composition of the diet.
1According to Maertens et al. (2002)
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The inoculum was administered orally with a plastic syringe at an inoculation dose of 500µl/doe. Each 
doe was inoculated with approximately:
1015 oocysts of E. magna
910 oocysts of E. media
280 oocysts of E. perforans
665 oocysts of E. intestinalis
630 oocysts of E. flavescens
The inoculation was done on Day 13 of the experiment. Non-pregnant females were also inoculated 13 d 
after the second insemination, if pregnant.
Clinical and parasitological parameters
Faecal samples were collected by placing a bucket under the cages of the rabbits. After homogenising, a 
representative sample was taken from each bucket. Faecal samples were only collected from females that 
were pregnant after the first artificial insemination and followed the initial time schedule.
Immediately after collection, the samples were transported for oocyst counts determination and/or 
differentiation to the DGZ-Flanders laboratory in Torhout (Belgium).
At the start of the study (Day 0), four pooled faecal samples from does, each consisting of 3 individual 
samples, were collected per group and the oocyst counts (OPG) were determined. On 19-24 d (control 
of artificial infection), 38-39 d (±7 d after the first kindling) and 84-86 d (±7 d after the second kindling) 
faecal samples were gathered. The OPG was determined on 5 pooled samples per group, each consisting 
of at least 3 individual samples. At the same time, differentiation was performed on 2 pooled samples 
per group, each consisting of ± 8 individual samples. On the samples collected on 55-57 d (±25 d after 
the first kindling) and 101-103 d (±25 d after the second kindling) only OPG counts were determined (5 
pooled samples per group).
Statistical analysis
Zootechnical parameters (prolificacy, weight development and feed intake) were analysed using the 
Kruskal Wallis Test. If a significant difference (α<0.05) was observed between groups, further statistical 
analysis was performed using the Mann-Whitney U test. Data concerning mortality or fertility were 
analysed by the χ² test. 
No statistical analysis was performed on the OPG values. Differences of more than 0.5 log were considered 
to be significantly different (i.e. reduction of the OPG by 50%).
RESULTS AND DISCUSSION
Concentration of robenidine hydrochloride in the experimental diets
The results of the dietary concentrations of robenidine are presented in Table 4. The analysed concentration 
in each sample was somewhat higher than intended. However, with the exception of the concentration 
found in sample C2, the difference between the analysed and intended inclusion rate was less than 10%. 
The difference between the analysed and intended rate for sample C2 was ±20%. Overall, it may be 
concluded that the difference between the intended and analysed concentrations was within an acceptable 
range.
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Zootechnical performance of the does and their offspring until weaning
It is a well known fact that the zootechnical performance (such as prolificacy, milk yield, feed intake,…) 
of breeding does is strongly influenced by the parity order (Maertens et al., 2006). For this reason, the 
cycle 1 and 2 results are presented separately. 
Cycle 1
The effect of the inoculation on the weight development of the does was clearly demonstrated in the 
inoculated non-treated group (I-NT group). The weight gain during the first 2 wk post infection was 
significantly different (P=0.048) between experimental groups (Table 5). Mean weight gain was 280, 
197, 289 and 240g in the NI-NT, I-NT, I-50 and I-66 does, respectively. This indicates that the objective 
of a quite severe infection was reached. Moreover, only females in the I-NT group showed signs of 
diarrhoea or wet faeces (prevalence >80%) between the 10th and 12th d post inoculation. These signs were 




First batch Sample A1 0 1,6 Feed 1 groups NI-NT and I-NT
Sample C1 50 53,8 Feed 1 group I-50
Sample D1 66 70,6 Feed 1 group I-66
Second batch Sample A2 0 <1,0 Feed 2 groups NI-NT and I-NT
Sample C2 50 60,3 Feed 2 group I-50
Sample D2 66 67,6 Feed 2 group I-66
Table 4: Analysed dietary concentration of robenidine in the different feed batches. 
Treatment NI-NT I-NT I-50 I-66 SEM P-value
Number of does 22 25 23 24 -
Mean body weight (g)
At insemination (1) 3828 3795 3910 3853 34 0.587
At inoculation (2) 4263 4202 4341 4307 35 0.549
14 d post inoculation (3) 4543 4400 4629 4548 37 0.168
7 d post kindling (4) 4553 4443 4610 4619 40 0.508
21 d post kindling (5) 4615 4503 4665 4678 44 0.612
At weaning (6) 4550 4563 4676 4749 47 0.396
Mean weight difference (g)
Interval (1) – (2) 435 408 431 454 16 0.800
Interval (2) – (3) 280a 197b 289a 240ab 15 0.048
Interval (3) – (4) 10 44 -19 71 18 0.226
Interval (4) – (5) 63 60 54 59 20 0.964
Interval (5) – (6) -65a 60b 11ab 71b 18 0.017
Table 5: Evolution of the mean body weight and weight gain of the does during their first cycle.
Means with different superscripts in the same row differ from each other (P<0.05).
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Differences in mean body weight were not significant at any of the 6 time points (P>0.05). Although not 
significantly different, the mean body weight of the I-NT group generally remained lower than that of the 
other groups during the first cycle. Unexpectedly, females from the NI-NT group lost weight (−65g) in 
the week before weaning (Figure 1); this can be explained by the presence of a natural and unintended 
infection with coccidiosis occurring in this period. Oocyst excretion during this period supports this 
hypothesis (see further). 
Average feed intake during the 14 d post infection was significantly lower (P<0.05) in I-NT does 
compared to controls and I-66 females (Table 6) and reached nearly the significance level (P=0.101) 
with I-50 females. These results confirm the impact of coccidiosis on the general health status and weight 
development of the breeding does in the first 14 d after infection. Afterwards, feed intake was comparable 
between the different experimental groups. 
The mean litter size at birth (total born/litter and live born/litter) was not significantly different between 
the different supplementation groups, although there was a tendency (P=0.103) towards a lower litter size 
at birth in the I-NT group and a higher litter size in the I-50 and I-66 groups (Table 7). After standardising 
(intra-group) of the litter size at 9 young, especially in the I-50 and I-66 groups, a considerable number of 
young were still available, so it was decided to use them partially to enlarge the litter size of I-NT litters. 
This explains why the litter size in I-NT litters after standardising (8.9) was higher than the initial live 
Treatment NI-NT I-NT I-50 I-66 SEM P-value
Number of does 22 25 23 24 - -
Mean feed intake (g/day/doe)
Period 1* 208 200 203 201 2.6 0.771
Period 2** 166a 139b 163ab 198c 4.6 < 0.000
Period 3*** 317 320 325 315 3.6 0.636
Table 6: Mean feed intake of does during the first cycle.



















   
Inoculation Parturition 1 Parturition 2
Figure 1: Weight development of does during the trial (g).
Maertens & Van GaVer
72
born young (only 8.2). The advantage of this approach is that the development of the young amongst the 
different groups became more comparable. 
The differences between the mean litter sizes were only significant 3 wk after kindling and at weaning 
(P<0.05). At the 3 wk time point, only the result from the I-66 group (8.8) differed significantly (P<0.05) 
from the other groups (8.2, 8.4 and 8.3 for NI-NT, I-NT, I-50, respectively). The mortality in the I-50 group 
was mainly caused by the high mortality in one litter and can therefore be considered as not treatment 
related. The mortality in the NI-NT group is more difficult to explain and could have been caused by the 
unintended natural infection with coccidiosis during this period, as is supported by the oocyst excretions 
during this period (See further). 
The mean litter and young weight must be interpreted in relation to the litter size. The litter size after 
the first week was comparable amongst the different supplementation groups, as shown in Table 7. At 
this time point, the litter weight of both supplemented groups was significantly (P<0.05) higher than the 
I-NT group (Table 8). This was not reflected in the mean young weight, although there was a tendency 
(P=0.119) towards a lower young weight in the I-NT group compared to both supplemented groups. 
After 3 wk, the litter size was significantly higher in the I-66 group and comparable to the other groups 
(Table 7). This clearly resulted, as expected, in a higher mean litter weight and a lower mean young weight 
in the I-66 group compared to the I-50 and NI-NT groups, although this difference was not statistically 
Treatment NI-NT I-NT I-50 I-66 SEM P-value
Number of does 22 25 23 24
Total born/litter 9.1 8.3 10.2 9.9 0.32 0.103
Born alive (n/litter) 9.0 8.2 10.1 9.8 0.33 0.123
Standardised at birth 8.7 8.9 9.0 9.0 0.03
Litter size after 1 wk 8.5 8.7 8.6 8.8 0.07 0.334
Litter size after 3 wk 8.2a 8.4a 8.3a 8.8b 0.09 0.027
Litter size at weaning 7.8a 8.3ab 7.8a 8.7b 0.12 0.017
Mortality 1 wk – weaning (%) 8.0c 4.5c 8.5c 1.0d - 0.003
Means with different superscripts in the same row differ from each other (P<0.05).
Table 7: Litter size during the first cycle.
Treatment NI-NT I-NT I-50 I-66 SEM P-value
Number of does 22 25 23 24
Litter weight after 1 wk (g) 1279ac 1273a 1373b 1364bc 21 0.037
Litter weight after 3 wk (g) 2580 2530 2710 2765 45 0.175
Litter weight at weaning (g) 5089 5240 5489 5706 107 0.133
Litter weight gain 1 wk - weaning 3810 3966 4116 4343 94 0.180
Young weight after 1 wk (g) 151 146 159 155 2.2 0.119
Young weight after 3 wk (g) 320 300 328 314 4.9 0.324
Young weight at weaning (g) 659ab 629a 699b 654a 10.0 0.033
Table 8: Mean litter weight and mean young weight during cycle 1.
Means with different superscripts in the same row differ from each other (P<0.05).
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significant. Mean litter and young weight in the I-NT group were lower than in the other groups, but the 
difference is not significant. 
The results at weaning are more difficult to interpret. At this time point, the NI-NT, I-NT and I-50 group 
had a comparable litter size (Table 7). The litter weight one week post parturition and the mean young 
weight at weaning in the I-50 group were significantly higher (P<0.05) than in the I-NT group and 
comparable to the NI-NT group (Table 8). The presence of an unintended natural infection in the NI-NT 
group during this time period, as is shown by the oocyst excretions during this period (see further), could 
also have influenced the results in this group. The I-66 group had a significantly higher (P<0.05) litter 
size than the NI-NT and I-55 group, which resulted in a lower mean young weight and a higher mean 
litter weight in comparison to the I-50 group, although this difference was not significant (P=0.133). 
The results in the I-66 group at weaning were not significantly different from those in the NI-NT or I-NT 
groups. 
Cycle 2
The weight evolution of the does was very comparable (Figure 1), although the does in the I-NT group 
always had a ± 200 g lower body weight. The only significant result was the loss of body weight in all 
groups at the end of cycle 2 (P=0.049). The NI-NT group had the lowest loss in body weight, followed 
by the I-NT group and both supplemented groups. This can be explained by the higher mean litter weight 
at weaning for the I-NT, I-50 and I-66 groups, although this difference was only marginally significant 
(P=0.069).
Litter size was high and exceeded 10 young/litter in all groups (Table 9). No differences in litter size were 
observed during cycle 2. The somewhat higher mortality in the NI-NT and I-50 groups was due to some 
exceptionally mortality in a limited number of litters (2 in both groups) and not relevant. A lack of milk 
was probably the cause.
Mean litter and young weight were comparable amongst the different supplementation groups, although 
litter weaning weight values for I-66 (litter 2) were higher but no significant (P=0.069) compared to the 
NI-NY litters. Differences in fertility (n° inseminated/n° parturitions) were not significantly different 
(P=0.309, data not shown). From the females that started the experiment, respectively 81.8, 88.0, 95.6 
and 95.8% of the NI-NT, I-NT, I-50 and I-66 group gave birth to second litters. Although the current trial 
was not powerful enough (limited n° females/group) to demonstrate a significant effect, such a difference 
of around 10% is not negligible in practice. 
Treatment NI-NT I-NT I-50 I-66 SEM P-value
Number of does at parturition 18 22 22 23 - -
Total born/litter 11.4 10.6 10.5 11.3 0.34 0.649
 Born alive (n/litter) 11.3 10.4 10.1 11.0 0.36 0.669
Litter size after 3 wk 8.8 9.3 8.6 9.5 0.16 0.251
Litter size at weaning 8.4 9.0 8.4 9.3 0.18 0.403
Litter weight at weaning (g) 6533 7002 7043 7419 141 0.069
Young weight at week 3 (g) 394 383 398 392 5.7 0.945
Young weight at weaning (g) 782 775 810 803 8.4 0.319
Mortality after week 1 (%) 9.2 4.5 8.1 4.2 - 0.163
Table 9: Overview of the performances during the 2nd cycle.
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Oocyst output and differentiation
Mean oocyst excretion during the first cycle is summarised in Figure 2. Results are presented as natural 
logarithms of the geometrical mean. At D0 of the study, all the oocyst counts were below the detection 
limit (<50). Thus, at the start of the trial the does were free of coccidia. 
On 13 d of the study, all the pregnant does were inoculated with the inoculum and faecal samples were 
collected from 6 to 11 d after the inoculation (period 19-24), which corresponds to shortest cycle (E. 
media and E. magna: 5-6 d) and the longest cycle (E. maxima and E. flavescens: 10-11 d) of the Eimeria 
spp. The oocyst excretion of both supplemented groups was reduced by more than 90% in comparison to 
the I-NT group, as shown in figure 2 (reduction by 1 logarithm). The NI-NT group initially remained free 
of coccidia, but apparently became infected approximately one week after kindling. The peak excretion 
of the NI-NT group was probably situated between D40 and D55.
Results from the species identification are presented in Figure 3. The excretion of E. flavescens and E. 
intestinalis, the 2 most pathogenic species, was reduced by 100% in both supplemented groups. Excretion 
of E. magna was reduced by 100% in the I-66 group and with more than 90% in the I-50 group. The 
reduction in oocyst excretion of E. media was less pronounced. The results of the OPGs and the species 
identification are in line with the clinical observation of diarrhoea in the I-NT group 10-12 d after infection. 
During this period, the NI-NT group remained free of coccidial infection.
Oocyst excretion 7 to 9 d after kindling (period D38-40) was overall low, but higher in the supplemented 
groups than in the I-NT. The results from the species identification demonstrate that the higher oocyst 
excretion in the supplemented groups is only due to the low pathogenic E. perforans and therefore of low 
importance. 
In the I-NT group the very pathogenic E. intestinalis and the pathogenic E. magna were still present 
during this period. In this period, the NI-NT group became naturally infected with E. magna, probably by 
cross-contamination.
In the last period of the first cycle, the oocyst excretion of the supplemented groups was practically 
zero. However, the infection remained present in the NI-NT group. During the second cycle, the oocyst 
excretions were very comparable between the different groups (counts ≤200) and no differentiation could 
be performed. The low infection pressure during the second cycle can be explained by the good hygienic 
conditions in this experimental facility and the development of immunity against the different Eimeria 
spp. Consequently, the results were very comparable amongst the different groups. 
Time period
Figure 3: Mean (geometric) oocyst excretion (OPG 
log10) per species for period 19-24 d.
Figure 2: Mean (geometric) oocyst excretion (OP 
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CONCLUSIONS
Cycostat® 66G supplemented in the feed at a concentration of 50 or 66 mg robenidine HCl/kg was able 
to prevent coccidiosis in breeding does after experimental inoculation with different rabbit specific 
Eimeria spp. No negative effects on the overall zootechnical performance (prolificacy, fertility, longevity 
and weight development) of breeding does and their progeny, nor on the mortality in the females and 
their young was observed by the dietary inclusion. On the contrary, the highest litter size at birth and at 
weaning was observed in females fed the diet with 66 mg. Supplementation with Cycostat 66G reduced 
the excretion of E. flavescens and E. intestinalis, the 2 most pathogenic species, by 100%, and caused a 
partial reduction of E. magna oocyst excretion, while the reduction in oocyst excretion of E. media was 
less pronounced.
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